Article
MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers.
Proceedings of the National Academy of Sciences of the United States of America - 9 Dec 2014
Mohseni Morassa, Cidado Justin, Croessmann Sarah, Cravero Karen, Cimino-Mathews Ashley, Wong Hong Yuen, Scharpf Rob, Zabransky Daniel J, Abukhdeir Abde M, Garay Joseph P, Wang Grace M, Beaver Julia A, Cochran Rory L, Blair Brian G, Rosen D Marc, Erlanger Bracha, Argani Pedram, Hurley Paula J, Lauring Josh, Park Ben Ho
Abstract excerpt
Tamoxifen is effective for treating estrogen receptor-alpha (ER) positive breast cancers. However, few molecular mediators of tamoxifen resistance have been elucidated. Here we describe a previously unidentified gene, MACROD2 that confers tamoxifen resistance and estrogen independent growth. We found MACROD2 is amplified and overexpressed in metastatic tamoxifen-resistant tumors. Transgene overexpression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
